CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 8 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,214 | +4.1% | 16,394 | +82.7% | 0.00% | – |
| Q2 2023 | $10,768 | – | 8,974 | +1511.1% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 557 | -86.0% | 0.00% | – |
| Q3 2022 | $5,000 | -58.3% | 3,979 | -40.4% | 0.00% | – |
| Q1 2022 | $12,000 | -29.4% | 6,678 | -41.3% | 0.00% | – |
| Q4 2021 | $17,000 | -10.5% | 11,373 | +21.3% | 0.00% | – |
| Q3 2021 | $19,000 | -45.7% | 9,375 | -7.1% | 0.00% | -100.0% |
| Q2 2021 | $35,000 | -61.1% | 10,096 | -80.0% | 0.00% | -50.0% |
| Q1 2021 | $90,000 | +900.0% | 50,356 | +497.2% | 0.00% | – |
| Q3 2020 | $9,000 | -71.0% | 8,432 | -69.6% | 0.00% | -100.0% |
| Q2 2020 | $31,000 | – | 27,720 | – | 0.00% | – |
| Q4 2017 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |